Download 06 - 2012 Emerging Medical Technologies Spotlight: A Report of... Partnering Opportunities

Brochure
More information from http://www.researchandmarkets.com/reports/2191572/
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment &
Partnering Opportunities
Description:
This report includes details on 39 emerging medical technology companies that have been identified by LSI's
in-house research team in June 2012.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on most of the companies.
Executive summaries typically include:
- Company Contact Information
- Company Overview (structure, size, year founded, etc.)
- Competitive Landscape
- Technological Advantage
- Stage of Development
- Target Markets
- Financial Summary and Sales Forecasts
- Financing & Partnering Needs
- IP Position & Status
- Management Team
- Exit Strategy
- More
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies
Contents:
- The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of
oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as
well as a disposable device that maximizes contact with the fluid or blood
- A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective
chemotherapy, avoiding damage to normal cells
- The Hemolung Respiratory Assist System, a respiratory dialysis product comprising a contoller, cartridge,
and catheter; intended to replace or supplement mechanical ventilation in Intensive Care Unit (ICU) patients
with acute hypercapnic respiratory failure
- Nanotechnology-based Point-of-Care products for the collection and screening of blood, urine, or oral
fluids
- 1. Vascular staplers for open surgery of abdominal aortic aneurysms (AAAs) or aorto-biliac/femoral
bypasses 2. Endovascular staplers for fixation of any current stent-grafts 3. Staplers for Critical Limb
Ischemia surgery, aiming to replace Femoro-Popliteal bypasses
- Ultrasound-guided cryothermally enhanced devices used to facilitate the site-specific C(2) (Cryo-Chemo)
Cancer Ablation Procedure, which delivers newly developed proprietary therapies to cancer sites while
avoiding toxic side effects
- A three-layered biological patch, called the LeucoPatch, which can be derived without additives from the
patient's blood within 20 minutes; used for chronically non-healing and debilitating wounds
- The ViSi Mobile System, a comprehensive vital signs monitoring platform for bedside, ambulatory, or
transport applications
- The CoolTools family of products, which target support/microcatheterization, local vascular drug delivery,
and selective hypothermia for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma)
- Intraurethral devices including a prostatic urethral stent and a urethral measurement device to enable the
selection of proper stent sizes
- Biological therapies targeting bone loss, blood and muscular weakness disorders, cancer, and rheumatoid
arthritis
- Corneal inlay for the treatment of near vision loss
- Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2
- Therapeutic antibodies discovered and optimized using somatic hypermutation (SHM)
- Offers technologies for drug delivery systems, including complex release products, fast-dispersing dosage
forms, and biodegradable polymers for custom release profiles in implants
- Targeted nanoparticles that selectively accumulate at disease sites and minimize the damage to healthy
tissues for the treatment of cancer, cardiovascular conditions, and inflammatory diseases
- Develops polymer composite products for biomedical applications, including clear braces for orthodontic
patients
- A continuous glucose monitoring device
- Diagnostic assays for joint fluid analysis; these technologies use a lateral flow immunoassay designs and
are used to rapidly detect the causes of joint pain
- An electrical stimulation device that targets the weak/dysfunctional lower esophageal sphincter in order to
treat severe Gastro Esophageal Reflux Disease (GERD)
- A glaucoma-detection technology that superimposes images of the posterior pole of the eye to show
changes over time
- Portable oxygen concentrator for active respiratory patients
- Microfluidic automation systems used for rapid DNA analysis
- A neurostimulation device for the treatment of lower back pain
- A highly-articulated multi-link robot that enables the performance of minimally invasive surgery
- Discreet sensors placed throughout the home for the purpose of monitoring elderly individuals
- Innovative protein, peptide, and antibody drug candidates for the treatment of cardiovascular disease,
diabetes, muscle wasting, and obesity
- Lenses that address vision problems associated with higher-order aberrations of the eye, improving vision,
contrast acuity, nighttime driving vision, and color dullness
- Innovative therapeutics for cardiovascular disease and autoimmune/inflammatory diseases that are based
on targets with established proof of concept and can offer advantages over existing therapies
- A pain management patch comprising a dressing and skin-friendly adhesive
- Orthopedic devices
- A cost-effective, efficient system for the production of ophthalmic lenses
- New antibacterial drugs that target multi-drug resistant pathogens
- Low-cost, portable ultrasound systems that offer bone and 3D imaging capabilities
- A fully-implantable continuous glucose monitoring system that utilizes fluorescence sensing technology
- Orthopedic plate and screw systems for large and small bone fragments
- A novel, short-peripheral intravenous (IV) catheter featuring a pre-assembled, closed design with highpressure extension tubing, a multi-use flow control clamp, and stabilization technology
- Portable x-ray technologies for medical applications
- External radiation therapy technology
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2191572/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment &
Partnering Opportunities
Web Address:
http://www.researchandmarkets.com/reports/2191572/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 395
Electronic (PDF) Enterprisewide:
USD 1975
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World